Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 188

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma

Open access
Vora, Parvez, Venugopal, Chitra, Salim, Sabra Khalid, Tatari, Nazanin, Bakhshinyan, David, Singh, Mohini, Seyfrid, Mathieu, Upreti, Deepak, Rentas, Stefan, Wong, Nicholas, Williams, Rashida, Qazi, Maleeha Ahmad, Chokshi, Chirayu, Ding, Avrilynn, Subapanditha, Minomi, Savage, Neil, Mahendram, Sujeivan, Ford, Emily, Adile, Ashley Ann, McKenna, Dillon, McFarlane, Nicole, Huynh, Vince, Wylie, Ryan Gavin, Pan, James, Bramson, Jonathan, Hope, Kristin, Moffat, Jason, Singh, Sheila · 2020 · Cell Stem Cell

Abstract

CD133 marks self-renewing cancer stem cells (CSCs) in a variety of solid tumors, and CD133+ tumor-initiating cells are known markers of chemo- and radio-resistance in multiple aggressive cancers, including glioblastoma (GBM), that may drive intra-tumoral heterogeneity. Here, we report three immunotherapeutic modalities based on a human anti-CD133 antibody fragment that targets a unique epitope present in glycosylated and non-glycosylated CD133 and studied their effects on targeting CD133+ cells in patient-derived models of GBM. We generated an immunoglobulin G (IgG) (RW03-IgG), a dual-antigen T cell engager (DATE), and a CD133-specific chimeric antigen receptor T cell (CAR-T): CART133. All three showed activity against patient-derived CD133+ GBM cells, and CART133 cells demonstrated superior efficacy in patient-derived GBM xenograft models without causing adverse effects on normal CD133+ hematopoietic stem cells in humanized CD34+ mice. Thus, CART133 cells may be a therapeutically tractable strategy to target CD133+ CSCs in human GBM or other treatment-resistant primary cancers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.stem.2020.04.008

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 188

Metadata

Authors
Vora, P., Venugopal, C., Salim, S. K., Tatari, N., Bakhshinyan, D., Singh, M., Seyfrid, M., Upreti, D., Rentas, S., Wong, N., Williams, R., Qazi, M. A., Chokshi, C., Ding, A., Subapanditha, M., Savage, N., Mahendram, S., Ford, E., Adile, A. A., McKenna, D., McFarlane, N., Huynh, V., Wylie, R. G., Pan, J., Bramson, J., Hope, K., Moffat, J., & Singh, S.
Venue
Cell Stem Cell
Publisher
Elsevier BV
Published
2020-06
Volume
26
Issue
6
Pages
832-844.e6
ISSN
  • 1875-9777 (ISSN-L)
  • 1934-5909
OpenAlex
W3029252496
Cited by
188
References
10
FWCI
11.80
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.